IDYA

Conviction 81HealthcareScan · Thu, Jun 25, 2026

Shooting star

IDYA$36.31+0.07%

ResistanceSupportVol 14

Vol MA14 1.8M

Mar 26Apr 14May 1May 19Jun 8Jun 25

IDEAYA Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.ideayabio.com ↗

Price36.31

Change+0.07%

Gap-0.59%

Rel volume2.16×

Avg volume1.52M

Avg $ vol47.38M

SMA 2030.58

SMA 5030.03

SMA 20031.42

Price vs 50+20.91%

Price vs 200+15.56%

MA stackmixed

50/200 cross—

Supertrendup · 31.64

RSI (14)73

MACD hist0.84

MACD cross—

Stoch %K / %D84 / 89

ADX (14)25

+DI / −DI39 / 9

RSI divergenceBullish

MACD divergence—

ATR %+4.77%

ADR %5.41%

52w high37.86

52w low21.02

From 52w high-4.11%

Above 52w low+72.72%

New 52w highNo

SqueezeOff

Bollinger width35.17%

%B1.03

Donchian pos83.80%

Donchian high38.14

Donchian low26.81

AVWAP (52w high)32.16

vs AVWAP high+12.89%

AVWAP (52w low)30.06

vs AVWAP low+20.78%

OBV trendUp

Chaikin MF (20)-0.07

Today vs 20d2.16×

Avg vol (14d)1.8M

Avg vol (20d)1.52M

Avg $ vol (20d)47.38M

Market cap3.19B

RS 3m (vs SPY)+6.58%

RS 6m (vs SPY)+0.40%

RS line new highNo

Trend template7/8

Technical rank76.9

1 week+16.14%

1 month+23.70%

3 months+15.66%

6 months+2.27%

1 year+66.69%

YTD+7.25%

P/E-28.05

P/B3.40

P/S14.58

P/FCF-43.42

EPS-1.28

Div yield—

ROE-12.13%

ROA-11.03%

Debt/Eq—

Current10.74

EV/EBITDA-19.36

Gross margin—

Net margin-51.99%

Rev growth3024.43%

EPS growth58.58%

Price target54.00

Target upside48.74%

Analyst ratingBuy

Institutional107.70%

Ent. value3.03B

Revenue6.56M

Net income-98.54M

Gross profit—

Free cash flow-73.47M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out87.86M

Employees145

ListedThu, May 23, 2019

Free float87.08M

Float %99.1%

Short interest11.34M

Days to cover16.3d

Short volume50.6%

Squeeze score73 / 100

Next earningsTue, Aug 4, 2026 (40d)

EPS forecast−$1.18 · 2 est

Last EPS vs est−$1.11 vs −$1.07

Last surprise-3.7% miss

Setup gradeA

Conviction81 / 100

Pattern quality—

Tech rank76.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IDYA

All disclosures →

No recent disclosed trades by Congress in IDYA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IDYA · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Hampton Malcolm Garret Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
MACKEY CATHERINE J Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
Morrison Scott W Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
ROSEN TERRY J Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
Stein Jeffrey Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
YARNO WENDY L Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in IDYA · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.